Ledger.Open graph →

SEC Form D · Amendment · filed January 14, 2020

INTARCIA THERAPEUTICS, INC

Offering

$280.0M

Sold

$198.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Boston, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (40)

Fred Fiedorek · Boston, MAExec Bryan Roberts · Boston, MADirector Kurt Graves · Boston, MAExec · Director Paul Feldman · Boston, MAExec Gino Santini · Boston, MADirector Jim Rosenthal · Boston, MADirector Bob Kerrey · Boston, MADirector Jay Skyler · Boston, MADirector Nancy Thornberry · Boston, MADirector Thane Wettig · Boston, MAExec Raymond Keane · Boston, MAExec Patrick Conway · Boston, MADirector Greg Fitzgerald · Austin, TXExec Greg Dracon · Austin, TXExec Ashish Kapoor · Toronto, Ontario, CanadaDirector Roslyn Hendriks · Seattle, WADirector Thomas Lendvay · Seattle, WAExec Bow Wave Capital Management, LP · New York, NYDirector Benjamin T. Higham · Toronto, Ontario, CanadaDirector Springdale Ventures, LLC · Austin, TXDirector Dan L. Graham · Austin, TXDirector Jeffrey Guy · Austin, TXDirector Mike Viscuso · Austin, TXExec Bow Wave Capital GP, LLC · New York, NYExec · Director Anders Vinther · Boston, MAExec David Spellman · Boston, MAExec William Howald · Vancouver, British Columbia, CanadaDirector Tony Wood · Vancouver, British Columbia, CanadaExec Oscar Rojas · San Francisco, CADirector Nigam Saraiya · Stamford, CTExec · Director Steven M. Kleiman · Deerfield, ILExec James G. Fuller · Sherman Oaks, CAExec Jeffrey Silverman · New Orleans, LAExec Benjamin Cappiello · New Orleans, LADirector Monica Metea · New Orleans, LADirector Michael Katz · New Orleans, LADirector J. Lowry Curley · New Orleans, LADirector Dale Pfost · New Orleans, LADirector Anders Vinther · Boston, MAExec David Spellman · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗